10 December 2024
Top global hires for large-cap, mid-cap and public companies H2-2024
Recent top global hires for large-cap, mid-cap, and public companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.
CEO/ C-suite/ Board
| Function | Focus area | Location |
|---|---|---|
| CEO | Medtech (publicly listed) | APAC |
| CEO | Life science tools (publicly listed) | Nordics |
| President Life Sciences | Specialty chemicals (large-cap) | UK & Ireland |
| Chief Financial Officer | Biotech (publicly listed) | US |
| Chief Financial Officer | Biopharma/ drug delivery (publicly listed) | UK & Ireland |
| Chief of Staff | Biopharma (publicly listed) | Europe |
| Chair | Mental health pharma (publicly listed) | US/ UK |
Commercial / Functional / Strategic Leadership
| Function | Focus area | Location |
|---|---|---|
| VP, Artificial Intelligence | Drug discovery (publicly listed) | UK & Ireland |
| Head of Corporate Business Development | Pharma (mid-cap) | Europe |
| Country Launch Distribution Head | Specialty pharma (mid-cap) | Europe |
| Head of Human Resources Europe | Pharma (publicly listed) | US |
| Country Head of Market Access | Platform technology (publicly listed) | Europe |
| Director, Innovation and New Technologies | Biopharma (publicly listed) | UK & Ireland |
| Country Senior Director, Pricing and Market Access | Biotech (large-cap) | US/ UK |
R&D/ Medical/ Technical
| Function | Focus area | Location |
|---|---|---|
| EVP/ Head of R&D/ Chief Medical Officer | Diversified pharma (publicly listed) | US |
| VP, Inflammation Rheumatology | Pharma (large-cap) | US |
| VP, Technical Operations | Drug technologies (mid-cap) | Europe |
| VP, Head of Obesity Development | Pharma (large-cap) | US |
| VP, Global Medical Affairs, Oncology | Pharma (large-cap) | US |
| Head of Quality Management | Biopharma (mid-cap) | Europe |
| Country Director, Medical Affairs | Pharma (mid-cap) | Europe |
| Director, Clinical Research | Specialty pharma (mid-cap) | Europe |
| Medical Director | Biopharma (publicly listed) | US |
| Quality Affairs Director | Animal health (large-cap) | Europe |
Related
-
Events
GIANT Health 2025
08 December 2025 – 09 December 2025
-
Company News
LSX World Congress conference with Justine McIlroy, Client Partner
12 May 2023
-
Thought Leadership
Five Shifts to Digital Personalized Healthcare
10 May 2023
-
Company News
Digital Health UK CEO and Commercial Leaders Breakfast
28 March 2023